Birdwatch Note
2024-10-07 12:34:23 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
引用元の記事で触れられている減量薬はGLP-1受容体作動薬であり、脳の満腹中枢に働きかけて食欲を抑制・胃の蠕動運動を抑えて満腹感を出すことで体重を減少させる薬です。 脂肪の分解を阻害し排出させる内臓脂肪減少薬とは異なります。 https://www.bloomberg.co.jp/news/articles/2024-05-10/SD9VTYDWRGG000 https://www.bloomberg.com/news/articles/2024-05-10/weight-loss-diabetes-drugs-like-ozempic-reach-one-in-eight-americans https://www.nagano-matsushiro.or.jp/feature/diet?pid=obesity_medication https://www.taisho.co.jp/company/news/2024/20240304001509.html
Written by E2BBE93A580C4BC6DF5FD6634273BC72CDCD1A4A5FBFD45D68810CFA1D6CD664
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1843208531111202976
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1843268633457488014
- noteId - 1843268633457488014
- participantId -
- noteAuthorParticipantId - E2BBE93A580C4BC6DF5FD6634273BC72CDCD1A4A5FBFD45D68810CFA1D6CD664 Participant Details
- createdAtMillis - 1728304463148
- tweetId - 1843208531111202976
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 引用元の記事で触れられている減量薬はGLP-1受容体作動薬であり、脳の満腹中枢に働きかけて食欲を抑制・胃の蠕動運動を抑えて満腹感を出すことで体重を減少させる薬です。 脂肪の分解を阻害し排出させる内臓脂肪減少薬とは異なります。 https://www.bloomberg.co.jp/news/articles/2024-05-10/SD9VTYDWRGG000 https://www.bloomberg.com/news/articles/2024-05-10/weight-loss-diabetes-drugs-like-ozempic-reach-one-in-eight-americans https://www.nagano-matsushiro.or.jp/feature/diet?pid=obesity_medication https://www.taisho.co.jp/company/news/2024/20240304001509.html
Note Ratings
rated at | rated by | |
2024-10-10 03:23:06 -0500 | Rating Details | |
2024-10-09 16:17:18 -0500 | Rating Details | |
2024-10-09 06:22:30 -0500 | Rating Details | |
2024-10-09 05:58:53 -0500 | Rating Details | |
2024-10-09 05:41:57 -0500 | Rating Details | |
2024-10-09 05:36:29 -0500 | Rating Details | |
2024-10-09 05:36:18 -0500 | Rating Details | |
2024-10-08 03:15:06 -0500 | Rating Details | |
2024-10-07 19:51:56 -0500 | Rating Details | |
2024-10-07 17:37:16 -0500 | Rating Details | |
2024-10-07 08:48:59 -0500 | Rating Details | |
2024-10-07 08:36:46 -0500 | Rating Details | |
2024-10-07 08:26:58 -0500 | Rating Details | |
2024-10-07 08:26:30 -0500 | Rating Details | |
2024-10-07 08:20:51 -0500 | Rating Details | |
2024-10-07 08:12:18 -0500 | Rating Details | |
2024-10-07 08:07:53 -0500 | Rating Details | |
2024-10-07 07:42:14 -0500 | Rating Details | |
2024-10-09 07:33:35 -0500 | Rating Details | |
2024-10-09 05:53:08 -0500 | Rating Details | |
2024-10-09 05:38:51 -0500 | Rating Details | |
2024-10-08 02:29:34 -0500 | Rating Details | |
2024-10-07 18:48:22 -0500 | Rating Details | |
2024-10-07 17:42:06 -0500 | Rating Details | |
2024-10-07 15:39:39 -0500 | Rating Details | |
2024-10-07 09:52:00 -0500 | Rating Details | |
2024-10-07 09:14:05 -0500 | Rating Details | |
2024-10-07 08:32:44 -0500 | Rating Details | |
2024-10-07 08:28:56 -0500 | Rating Details | |
2024-10-07 08:26:01 -0500 | Rating Details | |
2024-10-07 08:08:03 -0500 | Rating Details | |
2024-10-07 07:54:43 -0500 | Rating Details | |
2024-10-07 07:49:50 -0500 | Rating Details | |
2024-10-08 05:24:37 -0500 | Rating Details | |
2024-10-08 03:46:15 -0500 | Rating Details | |
2024-10-07 20:51:32 -0500 | Rating Details | |
2024-10-07 19:22:45 -0500 | Rating Details | |
2024-10-07 18:09:58 -0500 | Rating Details | |
2024-10-07 17:08:32 -0500 | Rating Details | |
2024-10-07 16:58:34 -0500 | Rating Details | |
2024-10-07 16:50:14 -0500 | Rating Details | |
2024-10-07 16:16:35 -0500 | Rating Details | |
2024-10-07 09:52:05 -0500 | Rating Details | |
2024-10-07 08:08:53 -0500 | Rating Details | |
2024-10-07 08:05:29 -0500 | Rating Details | |
2024-10-07 07:45:37 -0500 | Rating Details | |
2024-10-07 07:44:50 -0500 | Rating Details | |
2024-10-07 07:38:25 -0500 | Rating Details | |
2024-10-07 07:37:31 -0500 | Rating Details | |
2024-10-07 07:36:56 -0500 | Rating Details | |
2024-10-09 05:45:16 -0500 | Rating Details | |
2024-10-08 04:27:12 -0500 | Rating Details | |
2024-10-07 19:34:20 -0500 | Rating Details | |
2024-10-07 19:27:55 -0500 | Rating Details | |
2024-10-07 18:35:00 -0500 | Rating Details | |
2024-10-07 16:56:04 -0500 | Rating Details | |
2024-10-07 15:06:15 -0500 | Rating Details | |
2024-10-07 14:16:01 -0500 | Rating Details | |
2024-10-07 11:01:37 -0500 | Rating Details | |
2024-10-07 10:04:23 -0500 | Rating Details | |
2024-10-07 09:33:28 -0500 | Rating Details | |
2024-10-07 09:29:01 -0500 | Rating Details | |
2024-10-07 08:30:47 -0500 | Rating Details | |
2024-10-07 08:01:30 -0500 | Rating Details | |
2024-10-07 07:57:53 -0500 | Rating Details | |
2024-10-07 07:56:47 -0500 | Rating Details | |
2024-10-07 07:47:43 -0500 | Rating Details | |
2024-10-07 07:45:50 -0500 | Rating Details | |
2024-10-09 06:32:21 -0500 | Rating Details | |
2024-10-08 21:45:07 -0500 | Rating Details |